BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 27009852)

  • 21. Characterization of TAZ domains important for the induction of breast cancer stem cell properties and tumorigenesis.
    Li YW; Shen H; Frangou C; Yang N; Guo J; Xu B; Bshara W; Shepherd L; Zhu Q; Wang J; Hu Q; Liu S; Morrison CD; Sun P; Zhang J
    Cell Cycle; 2015; 14(1):146-56. PubMed ID: 25602524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia inducible factor-1 is activated by transcriptional co-activator with PDZ-binding motif (TAZ) versus WWdomain-containing oxidoreductase (WWOX) in hypoxic microenvironment of bone metastasis from breast cancer.
    Bendinelli P; Maroni P; Matteucci E; Luzzati A; Perrucchini G; Desiderio MA
    Eur J Cancer; 2013 Jul; 49(11):2608-18. PubMed ID: 23566416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of the Hippo Pathway Transcription Factor TEAD.
    Lin KC; Park HW; Guan KL
    Trends Biochem Sci; 2017 Nov; 42(11):862-872. PubMed ID: 28964625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma.
    Kaneda A; Seike T; Danjo T; Nakajima T; Otsubo N; Yamaguchi D; Tsuji Y; Hamaguchi K; Yasunaga M; Nishiya Y; Suzuki M; Saito JI; Yatsunami R; Nakamura S; Sekido Y; Mori K
    Am J Cancer Res; 2020; 10(12):4399-4415. PubMed ID: 33415007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins.
    Kanai F; Marignani PA; Sarbassova D; Yagi R; Hall RA; Donowitz M; Hisaminato A; Fujiwara T; Ito Y; Cantley LC; Yaffe MB
    EMBO J; 2000 Dec; 19(24):6778-91. PubMed ID: 11118213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling.
    Zhao Y; Yang X
    Oncotarget; 2015 Sep; 6(26):21906-17. PubMed ID: 26183396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leveraging the Fragment Molecular Orbital and MM-GBSA Methods in Virtual Screening for the Discovery of Novel Non-Covalent Inhibitors Targeting the TEAD Lipid Binding Pocket.
    Kim J; Jin H; Kim J; Cho SY; Moon S; Wang J; Mao J; No KT
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Green fluorescent protein-tagging reduces the nucleocytoplasmic shuttling specifically of unphosphorylated STAT1.
    Meyer T; Begitt A; Vinkemeier U
    FEBS J; 2007 Feb; 274(3):815-26. PubMed ID: 17288561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Truncated TEAD-binding protein of TAZ inhibits glioma survival through the induction of apoptosis and repression of epithelial-mesenchymal transition.
    Zhao W; Li LW; Tian RF; Dong QF; Li PQ; Yan ZF; Yang X; Huo JL; Fei Z; Zhen HN
    J Cell Biochem; 2019 Oct; 120(10):17337-17344. PubMed ID: 31209945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition.
    Zhang H; Liu CY; Zha ZY; Zhao B; Yao J; Zhao S; Xiong Y; Lei QY; Guan KL
    J Biol Chem; 2009 May; 284(20):13355-13362. PubMed ID: 19324877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members.
    Mahoney WM; Hong JH; Yaffe MB; Farrance IK
    Biochem J; 2005 May; 388(Pt 1):217-25. PubMed ID: 15628970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a novel compound that promotes myogenesis via Akt and transcriptional co-activator with PDZ-binding motif (TAZ) in mouse C2C12 cells.
    Kodaka M; Mao F; Arimoto-Matsuzaki K; Kitamura M; Xu X; Yang Z; Nakagawa K; Maruyama J; Ishii K; Akazawa C; Oyaizu T; Yamamoto N; Ishigami-Yuasa M; Tsuemoto N; Ito S; Kagechika H; Nishina H; Hata Y
    PLoS One; 2020; 15(4):e0231265. PubMed ID: 32267872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TEADs mediate nuclear retention of TAZ to promote oncogenic transformation.
    Chan SW; Lim CJ; Loo LS; Chong YF; Huang C; Hong W
    J Biol Chem; 2009 May; 284(21):14347-58. PubMed ID: 19324876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway Signaling.
    Holden JK; Crawford JJ; Noland CL; Schmidt S; Zbieg JR; Lacap JA; Zang R; Miller GM; Zhang Y; Beroza P; Reja R; Lee W; Tom JYK; Fong R; Steffek M; Clausen S; Hagenbeek TJ; Hu T; Zhou Z; Shen HC; Cunningham CN
    Cell Rep; 2020 Jun; 31(12):107809. PubMed ID: 32579935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional complexes between YAP2 and ZO-2 are PDZ domain-dependent, and regulate YAP2 nuclear localization and signalling.
    Oka T; Remue E; Meerschaert K; Vanloo B; Boucherie C; Gfeller D; Bader GD; Sidhu SS; Vandekerckhove J; Gettemans J; Sudol M
    Biochem J; 2010 Dec; 432(3):461-72. PubMed ID: 20868367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the Hippo Pathway for Anti-cancer Therapies.
    Gong R; Yu FX
    Curr Med Chem; 2015; 22(35):4104-17. PubMed ID: 26429069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of FAM181A and FAM181B as new interactors with the TEAD transcription factors.
    Bokhovchuk F; Mesrouze Y; Delaunay C; Martin T; Villard F; Meyerhofer M; Fontana P; Zimmermann C; Erdmann D; Furet P; Scheufler C; Schmelzle T; Chène P
    Protein Sci; 2020 Feb; 29(2):509-520. PubMed ID: 31697419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway.
    Lei QY; Zhang H; Zhao B; Zha ZY; Bai F; Pei XH; Zhao S; Xiong Y; Guan KL
    Mol Cell Biol; 2008 Apr; 28(7):2426-36. PubMed ID: 18227151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TAZ interacts with TTF-1 and regulates expression of surfactant protein-C.
    Park KS; Whitsett JA; Di Palma T; Hong JH; Yaffe MB; Zannini M
    J Biol Chem; 2004 Apr; 279(17):17384-90. PubMed ID: 14970209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The TEAD4-YAP/TAZ protein-protein interaction: expected similarities and unexpected differences.
    Hau JC; Erdmann D; Mesrouze Y; Furet P; Fontana P; Zimmermann C; Schmelzle T; Hofmann F; Chène P
    Chembiochem; 2013 Jul; 14(10):1218-25. PubMed ID: 23780915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.